Author:
Serik S.A., ,Strona V.I.,
Abstract
The article analyzes the main clinical and theoretical data on the features of the treatment of atrial fibrillation (AF) in combination with diabetes mellitus (DM). Differentiated approaches to the correction of these cardiac arrhythmias in this category of patients are considered, among which the methods of first choice are hypoglycemic therapy and catheter ablation. Currently, in addition to metformin, which is the basis for the treatment of most patients with type 2 diabetes, new classes of drugs are used: sodium glucose co-transporter-2 (SGLT2) inhibitors, agonists of the receptor for glucagon-like peptide-1 (aGPP-1), dipeptidyl peptidase 4 (DPP-4) inhibitors. The results of randomized trials performed using these classes of drugs have shown different levels of cardiac efficacy and safety in the treatment of patients with AF.
Publisher
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
Reference137 articles.
1. 1. Bilovol, O. M., Kniazkova, I. I. Shchodo pytannia pro vedennia litnoho patsiienta z fibryliatsiieiu peredserd// Liky Ukrainy. 2021;8(254):20-26. Ukrainian. https://doi. org/10.37987/1997-9894.2021.8(254).245797
2. 2. Zhuravlyova LV, Sokolnikova NV, Rogachova TA. Vzaiemozviazok tsukrovoho diabetu i porushen rytmu sertsia: fokus na spilni patofiziolohichni mekhanizmy i suchasni metody likuvannia. [The relationship between diabetes mellitus and heart rhythm disorders: a focus on common pathophysiological mechanisms and modern treatment strategies]. Shidnoevr. z. vnutr. simejnoi med. 2021;2:22-27. Ukrainian. doi: 10.15407/internalmed2021.02.022
3. 3. Koval S.M., Yushko K.O. Tsukrovyi diabet 2 typu ta sertsevo-sudynni zakhvoriuvannia. Chastyna I. Vyznachennia problemy, stratyfikatsiia kardiovaskuliarnoho ryzyku i osnovni napriamky profilaktyky sertsevo-sudynnykh zakhvoriuvan u khvorykh na tsukrovyi diabet 2 typu. Arteryalnaia hypertenzyia. 2020;13(5):11-19. Ukrainian
4. 4. Serik SA, Strona VI. Fibrillyaciya predserdij u bol'nykh sakharnym diabetom. [Atrial fibrillation in diabetic patients]. Shidnoevr. z. vnutr. simejnoi med. 2021;2:103-117. Russian. doi: 10.15407/internalmed2021.02.103
5. 5. Flomin Ju. V. , Get'man T. V. , Romanova E. N. , Irkin O.I. Antikoaguljantnaja terapija u pacientov s neklapannoj fibrilljaciej predserdij: kakimi innovacionnymi vozmozhnostjami my raspolagaem segodnja? Russsian. Avalible from https:// health-ua.com/article/42970-antikoagulyantnaya-terapiyau-patcientov-s-neklapannoj-fibrillyatciej-preds.